Studebaker, A. W., Hutzen, B. J., Pierson, C. R., Haworth, K. B., Cripe, T. P., Jackson, E. M., & Leonard, J. R. (2017). Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors. Mol Ther Oncolytics.
Citação norma ChicagoStudebaker, Adam W., Brian J. Hutzen, Christopher R. Pierson, Kellie B. Haworth, Timothy P. Cripe, Eric M. Jackson, and Jeffrey R. Leonard. "Oncolytic Herpes Virus RRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors." Mol Ther Oncolytics 2017.
Citação norma MLAStudebaker, Adam W., et al. "Oncolytic Herpes Virus RRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors." Mol Ther Oncolytics 2017.